Computational and experimental exploration of the structure-activity relationships of flavonoids as potent glyoxalase-I inhibitors

被引:19
作者
Al-Balas, Qosay A. [1 ]
Hassan, Mohammad A. [1 ]
Al-Shar'i, Nizar A. [1 ]
El-Elimat, Tamam [1 ]
Almaaytah, Ammar M. [2 ]
机构
[1] Jordan Univ Sci & Technol, Dept Med Chem & Pharmacognosy, Irbid 22110, Jordan
[2] Jordan Univ Sci & Technol, Dept Pharmaceut Technol, Irbid 22110, Jordan
关键词
flavonoids; glyoxalase-I; metalloenzyme; molecular docking; structure-activity relationship; zinc-chelation; GREEN TEA; PATHWAY; EGCG;
D O I
10.1002/ddr.21421
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Glyoxalase-I (Glo-I) enzyme has emerged as a potential target for cancer treatment. Several classes of natural products including coumarins and flavonoids have shown remarkable Glo-I inhibitory activity. In the present study, computational and experimental approaches were used to explore the structure-activity relationships of a panel of 24 flavonoids as inhibitors of the Glo-1 enzyme. Scutellarein with an IC50 value of 2.04 M was identified as the most potent inhibitor among the series studied. Di- or tri-hydroxylation of the benzene rings A and B accompanied with a C2/C3 double bond in ring C were identified as essential structural features for enzyme inhibition. Moreover, the ketol system showed a minor role in the inhibitory power of these compounds. The structure-activity relationships revealed in this study had deepened our understanding of the Glo-I inhibitory activities of flavonoids and opened the door for further exploration of this promising compound class.
引用
收藏
页码:58 / 69
页数:12
相关论文
共 25 条
  • [1] Al-Balas Q. A., 2017, LETT DRUG DES DISCOV, V14, P1
  • [2] Generation of the First Structure-Based Pharmacophore Model Containing a Selective "Zinc Binding Group" Feature to Identify Potential Glyoxalase-1 Inhibitors
    Al-Balas, Qosay
    Hassan, Mohammad
    Al-Oudat, Buthina
    Alzoubi, Hassan
    Mhaidat, Nizar
    Almaaytah, Ammar
    [J]. MOLECULES, 2012, 17 (12): : 13740 - 13758
  • [3] Novel glyoxalase-I inhibitors possessing a "zinc-binding feature" as potential anticancer agents
    Al-Balas, Qosay A.
    Hassan, Mohammad A.
    Al-Shar'i, Nizar A.
    Mhaidat, Nizar M.
    Almaaytah, Ammar M.
    Al-Mahasneh, Fatima M.
    Isawi, Israa H.
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 2623 - 2629
  • [4] Crystal structure of human glyoxalase .1. Evidence for gene duplication and 3D domain swapping
    Cameron, AD
    Olin, B
    Ridderstrom, M
    Mannervik, B
    Jones, TA
    [J]. EMBO JOURNAL, 1997, 16 (12) : 3386 - 3395
  • [5] Reaction mechanism of glyoxalase I explored by an X-ray crystallographic analysis of the human enzyme in complex with a transition state analogue
    Cameron, AD
    Ridderström, M
    Olin, B
    Kavarana, MJ
    Creighton, DJ
    Mannervik, B
    [J]. BIOCHEMISTRY, 1999, 38 (41) : 13480 - 13490
  • [6] Speaking Stata: Correlation with confidence, or Fisher's z revisited
    Cox, Nicholas J.
    [J]. STATA JOURNAL, 2008, 8 (03) : 413 - 439
  • [7] Epigallocatechin Gallate (EGCG) Is the Most Effective Cancer Chemopreventive Polyphenol in Green Tea
    Du, Guang-Jian
    Zhang, Zhiyu
    Wen, Xiao-Dong
    Yu, Chunhao
    Calway, Tyler
    Yuan, Chun-Su
    Wang, Chong-Zhi
    [J]. NUTRIENTS, 2012, 4 (11): : 1679 - 1691
  • [8] Anticancer effects and molecular mechanisms of epigallocatechin-3-gallate
    Min, Kyoung-jin
    Kwon, Taeg Kyu
    [J]. INTEGRATIVE MEDICINE RESEARCH, 2014, 3 (01) : 16 - 24
  • [9] Design, synthesis, and binding studies of bidentate Zn-chelating peptidic inhibitors of glyoxalase-I
    More, Swati S.
    Vince, Robert
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (13) : 3793 - 3797
  • [10] A metabolically stable tight-binding transition-state inhibitor of glyoxalase-I
    More, Swati S.
    Vince, Robert
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (23) : 6039 - 6042